Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News EGF Theramed Health Corp EVAHF


Primary Symbol: C.TMED

EGF Theramed Health Corp. is a Canada-based consumer technology company engaged in the provision of biomedical online services for monitoring and treating common health problems. The Company, through its subsidiaries, has assets and technologies used in the extraction and purification of botanical extracts and the creation of extract formulations, as well as medical monitoring device technology... see more

Recent & Breaking News (CSE:TMED)

EGF Theramed Health Comments Further on Recent Market Activity at the Request of OTC Markets

Accesswire May 25, 2020

EGF Theramed Health Announces $2 Million Financing and Joint Venture with Acquisition of 40% Interest in Biosynthesis and Wellness Company, Green Parrot Labs

Accesswire May 22, 2020

EGF Theramed Health Comments on Recent Market Activity

Accesswire May 19, 2020

EGF Theramed Appoints George Anstey to Board of Directors

Accesswire May 15, 2020

Theramed Announces Further Developments in Pharmadelic Labs Intellectual Property

Accesswire May 14, 2020

EGF Theramed Health Closes Joint Venture With Acquisition Of 30% Interest Of Biosynthesis Company, Pharmadelic Labs

Accesswire May 6, 2020

EGF Theramed Health Corp. Announces $1.7m Non-brokered Private Placement and Early Stage Due Diligence on Psilocybin Assets

Newsfile April 13, 2020

EGF Theramed Announces Resignation of Director and President

Newsfile April 3, 2020

EGF Theramed Announces Change of CFO and Director

Accesswire February 5, 2020

EGF Theramed Announces Change of Directors and New CEO

Newsfile January 30, 2020

IIROC Trade Resumption - TMED

Canada NewsWire November 27, 2019

IIROC Trading Halt - TMED

Canada NewsWire November 4, 2019

IIROC Trade Resumption - TMED

Canada NewsWire October 25, 2019

EGF Theramed Comments on Trading Halt and Confirms Share Consolidation and Trading on a Post Consolidated Basis

Accesswire October 24, 2019

IIROC Trading Halt - TMED

Canada NewsWire October 24, 2019

Theramed Announces Receipt of New ISIN, CUSIP for EGF Theramed Health Corp and Consolidation

Accesswire October 18, 2019

Theramed Announces Modification of Operating Name to EGF Theramed Health Corp.

Accesswire October 4, 2019

Theramed Provides Operational Update for Nevada Lab

Accesswire September 17, 2019

Theramed Announces Launch of Development Initiative for Asia Pacific Region to be Named EGF-Theramed Health

Accesswire September 5, 2019

Theramed Announces Closing of $350,000 of Senior Convertible Notes to Fund Extraction Operations

Accesswire August 12, 2019